title: Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Mantengoli
authors.forename: Francesco
authors.initials: F
authors.lastname: Luzzaro
authors.forename: Patrizia
authors.initials: P
authors.lastname: Pecile
authors.forename: Daniela
authors.initials: D
authors.lastname: Cecconi
authors.forename: Annalisa
authors.initials: A
authors.lastname: Cavallo
authors.forename: Letizia
authors.initials: L
authors.lastname: Attala
authors.forename: Alessandro
authors.initials: A
authors.lastname: Bartoloni
authors.forename: Gian Maria
authors.initials: GM
authors.lastname: Rossolini
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015373:Bacterial Typing Techniques; D024901:Drug Resistance, Multiple, Bacterial; D004926:Escherichia coli / Q000145:classification / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000382:microbiology*; D005838:Genotype; D006801:Humans; D008826:Microbial Sensitivity Tests; D058889:Molecular Typing; D001618:beta-Lactamases / Q000096:biosynthesis*
chemical_list: D000900:Anti-Bacterial Agents; D001618:beta-Lactamases